As the January 1 implementation date approaches, here is a quick guide to the controversial new rebate model for the 340B Drug Pricing Program and the legal battle to stop it.

Tariffs will also play a significant role in the success of the stock in 2026. If the Trump Administration stays the course with tariff pressure, P&G might have a repeat down year. Back in July, the ...

The US Court of Appeals for the Federal Circuit denied mandamus relief to three petitioners after the United States Patent and Trademark Office (USPTO) denied inter partes review (IPR) institution.

Bill Roth, general manager and managing partner of IntegriChain’s consulting business, previews his new six-part series by ...